Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Hold
750
0.13% 75
2026
Q1
$264K Sell
750
-21
-3% -$7.49K 0.13% 71
2025
Q4
$252K Buy
771
+21
+3% +$6.66K 0.13% 67
2025
Q3
$212K Hold
750
0.11% 76
2025
Q2
$209K Hold
750
0.11% 76
2025
Q1
$234K Hold
750
0.13% 64
2024
Q4
$195K Sell
750
-15
-2% -$4.45K 0.11% 66
2024
Q3
$247K Sell
765
-1
-0.1% -$327 0.14% 58
2024
Q2
$239K Hold
766
0.14% 60
2024
Q1
$218K Hold
766
0.13% 66
2023
Q4
$221K Buy
+766
New +$209K 0.15% 64

Other funds holding AMGN

Birchbrook's AMGN Position: Q2 2026 in Review

Birchbrook held its Amgen (AMGN) position steady in Q2 2026 at 750 shares worth $272K. The position accounts for 0.13% of the portfolio, ranked #75.

Birchbrook first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,247 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Birchbrook held 750 shares of Amgen worth $272K as of Q2 2026.
  • Birchbrook left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.13% of Birchbrook's portfolio in Q2 2026, its #75 holding.
  • Birchbrook first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 1,247 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Birchbrook's 13F filing for Q2 2026, filed 9 Jul 2026.